Please assess the completion status of the following clinical trial:

Trial Title: Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Greater than one year history of migraine~* Attacks typically mild when they begin and progress to moderate or severe~* Experience 1-4 migraine attacks per month~Exclusion Criteria:~* More than 15 headache days per month~* Heart disease~* Uncontrolled high blood pressure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Active Drug
- 2 (Type: PLACEBO_COMPARATOR): Matching Pbo Comparator

Based on this trial design, predict the completion outcome and termination type (if applicable).